Research ExplorerPublicationsMetastatic Germ Cell Cancer: The Intermediate-Prognosis Risk...

Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category

Standard

Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category. / Bokemeyer, Carsten; Seidel, Christoph.

Diagnosis and Management of Testicular Cancer: The European Point of View. ed. / Susanne Krege. Vol. Part II 1. ed. Springer, 2015. p. 55-64.

Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

Harvard

Bokemeyer, C & Seidel, C 2015, Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category. in S Krege (ed.), Diagnosis and Management of Testicular Cancer: The European Point of View. 1 edn, vol. Part II, Springer, pp. 55-64. https://doi.org/10.1007/978-3-319-17467-9, https://doi.org/10.1007/978-3-319-17467-9_5

APA

Bokemeyer, C., & Seidel, C. (2015). Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category. In S. Krege (Ed.), Diagnosis and Management of Testicular Cancer: The European Point of View (1 ed., Vol. Part II, pp. 55-64). Springer. https://doi.org/10.1007/978-3-319-17467-9, https://doi.org/10.1007/978-3-319-17467-9_5

Vancouver

Bokemeyer C, Seidel C. Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category. In Krege S, editor, Diagnosis and Management of Testicular Cancer: The European Point of View. 1 ed. Vol. Part II. Springer. 2015. p. 55-64 https://doi.org/10.1007/978-3-319-17467-9, https://doi.org/10.1007/978-3-319-17467-9_5

Bibtex

@inbook{adfb3dfc0e704bc5991bbe9c5b180bd2,
title = "Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category",
abstract = "This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.",
author = "Carsten Bokemeyer and Christoph Seidel",
year = "2015",
doi = "10.1007/978-3-319-17467-9",
language = "English",
isbn = "978-3-319-17466-2",
volume = "Part II",
pages = "55--64",
editor = "Krege, {Susanne }",
booktitle = "Diagnosis and Management of Testicular Cancer",
publisher = "Springer",
address = "Germany",
edition = "1",

}

RIS

TY - CHAP

T1 - Metastatic Germ Cell Cancer: The Intermediate-Prognosis Risk Category

AU - Bokemeyer, Carsten

AU - Seidel, Christoph

PY - 2015

Y1 - 2015

N2 - This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.

AB - This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.

U2 - 10.1007/978-3-319-17467-9

DO - 10.1007/978-3-319-17467-9

M3 - SCORING: Contribution to collected editions/anthologies

SN - 978-3-319-17466-2

VL - Part II

SP - 55

EP - 64

BT - Diagnosis and Management of Testicular Cancer

A2 - Krege, Susanne

PB - Springer

ER -